[CLSTR]
< Back to situations

[PERSON]

Vikram Nath

Featured in 11 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [IN]

Indian Supreme Court litigation over counterfeit medicines

6 clusters · 38 sources · last updated

Latest: India proposes 30% trade margin cap on cancer drugs

Advocate Ashwini Upadhyay filed a Public Interest Litigation (PIL) in the Supreme Court of India seeking a uniform national framework to address the manufacture and sale of counterfeit and adulterated medicines. The peti

[QUIET] [TECHNOLOGY] [US] [AU] [GB]

Enterprise AI scaling faces governance and regulatory shifts

137 clusters · 587 sources · last updated

Latest: Data quality and governance identified as critical factors for AI success

By late 2026, the gap between AI adoption and cybersecurity preparedness has widened. While AI has transitioned to core infrastructure within U.S. state governments, the ISACA 2026 State of Cybersecurity report notes tha

[QUIET] [HEALTH] [IN]

Indian medical and pharmaceutical ethics regulation

2 clusters · 9 sources · last updated

Latest: Supreme Court directs Centre to form panel on unethical pharma marketing

In India, regulatory and judicial actions have been taken to address ethical concerns within the medical and pharmaceutical sectors. The National Medical Commission (NMC) issued new guidelines to regulate advertising an

Also covered in